loadpatents
name:-0.049520969390869
name:-0.030128002166748
name:-0.0070688724517822
Majuru; Shingai Patent Filings

Majuru; Shingai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Majuru; Shingai.The latest application filed is for "crystalline polymorphic forms of monosodium n-[-8-(2-hydroxybenzoyl)amino]caprylate".

Company Profile
7.35.47
  • Majuru; Shingai - Brewster NY
  • Majuru; Shingai - Greensboro NC
  • MAJURU; Shingai - Mebane NC
  • MAJURU; Shingai - Saxapahaw NC
  • Majuru; Shingai - Tarrytown NY US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Crystalline polymorphic forms of monosodium n-[-8-(2-hydroxybenzoyl)amino]caprylate
Grant 11,395,809 - Levchik , et al. July 26, 2
2022-07-26
Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
App 20210177792 - Levchik; Halina ;   et al.
2021-06-17
Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
Grant 10,744,105 - Levchik , et al. A
2020-08-18
Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
App 20190343786 - Levchik; Halina ;   et al.
2019-11-14
Gastric Retention and Controlled Release Delivery System
App 20190216729 - Liao; Jun ;   et al.
2019-07-18
Powder Oral Suspension Formulations Of Antibacterial Agents
App 20190209530 - PEREIRA; David Eugene ;   et al.
2019-07-11
Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
Grant 10,188,621 - Levchik , et al. Ja
2019-01-29
Pharmaceutical Formulations Containing Microparticles Or Nanoparticles Of A Delivery Agent
App 20190022228 - Klein; George ;   et al.
2019-01-24
Silk-based capsules
Grant 10,182,991 - Dyakonov , et al. Ja
2019-01-22
Formulations For Delivering Insulin
App 20180338923 - LEVCHIK; Halina ;   et al.
2018-11-29
Silk-based Capsules
App 20180235892 - DYAKONOV; Tatyana ;   et al.
2018-08-23
Silk-based capsules
Grant 9,968,561 - Dyakonov , et al. May 15, 2
2018-05-15
Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
App 20170326087 - Levchik; Halina ;   et al.
2017-11-16
Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
Grant 9,750,710 - Levchik , et al. September 5, 2
2017-09-05
Powder Oral Suspension Formulations Of Antibacterial Agents
App 20170224664 - PEREIRA; David Eugene ;   et al.
2017-08-10
Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
App 20160184251 - LEVCHIK; Halina ;   et al.
2016-06-30
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
Grant 9,370,492 - Ahmed , et al. June 21, 2
2016-06-21
Gallium nitrate formulations
Grant 9,364,502 - Majuru , et al. June 14, 2
2016-06-14
Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
Grant 9,321,719 - Levchik , et al. April 26, 2
2016-04-26
Silk-based Capsules
App 20160045443 - DYAKONOV; Tatyana ;   et al.
2016-02-18
Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
Grant 9,238,074 - Dhoot , et al. January 19, 2
2016-01-19
Formulations For Delivering Insulin
App 20150190344 - LEVCHIK; Halina ;   et al.
2015-07-09
Oral insulin therapies and protocol
Grant 8,962,554 - Arbit , et al. February 24, 2
2015-02-24
Acyclovir formulations
Grant 8,952,017 - Adams , et al. February 10, 2
2015-02-10
Formulations for delivering insulin
Grant 8,927,015 - Levchik , et al. January 6, 2
2015-01-06
Oral Insulin Therapies And Protocol
App 20140206612 - ARBIT; Ehud ;   et al.
2014-07-24
Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
App 20140187813 - LEVCHIK; Halina ;   et al.
2014-07-03
Oral insulin therapies and protocol
Grant 8,729,016 - Arbit , et al. May 20, 2
2014-05-20
Disodium salts, monohydrates, and ethanol solvates for delivering active agents
Grant 8,658,695 - Bay , et al. February 25, 2
2014-02-25
Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
Grant 8,636,996 - Levchik , et al. January 28, 2
2014-01-28
Crystalline Forms Of The Di-sodium Salt Of N-(5-chlorosalicyloyl)-8-aminocaprylic Acid
App 20130303444 - DHOOT; Nikhil ;   et al.
2013-11-14
Acyclovir Formulations
App 20130281471 - ADAMS; Amy C. ;   et al.
2013-10-24
Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
Grant 8,431,736 - Dhoot , et al. April 30, 2
2013-04-30
Disodium Salts, Monohydrates, And Ethanol Solvates For Delivering Active Agents
App 20120264834 - BAY; William E. ;   et al.
2012-10-18
Acyclovir Formulations
App 20120238591 - MAJURU; Shingai ;   et al.
2012-09-20
Pharmaceutical Formulations Containing Microparticles Or Nanoparticles Of A Delivery Agent
App 20120189666 - Dhoot; Nikhil ;   et al.
2012-07-26
Disodium salts, monohydrates, and ethanol solvates for delivering active agents
Grant 8,207,227 - Bay , et al. June 26, 2
2012-06-26
Crystalline Forms Of The Di-sodium Salt Of N-(5-chlorosalicyloyl)-8-aminocaprylic Acid
App 20120065128 - DHOOT; Nikhil ;   et al.
2012-03-15
Solid dosage form of wetted heparin
Grant 8,039,018 - Majuru , et al. October 18, 2
2011-10-18
Disodium Salts, Monohydrates, And Ethanol Solvates For Delivering Active Agents
App 20110251125 - Bay; William E. ;   et al.
2011-10-13
Crystalline forms of the di-sodium salt of N-(5-Chlorosalicyloyl)-8-aminocaprylic acid
Grant 8,026,392 - Dhoot , et al. September 27, 2
2011-09-27
Amorphous sodium 4-[4-chloro-2-hydroxybenzoyl)amino]butanoate
Grant 7,893,297 - Bhandarkar , et al. February 22, 2
2011-02-22
Gallium Nitrate Formulations
App 20100239658 - Majuru; Shingai ;   et al.
2010-09-23
Disodium Salts, Monohydrates, And Ethanol Solvates For Delivering Active Agents
App 20100099621 - Bay; William E. ;   et al.
2010-04-22
Acyclovir Formulations
App 20100069410 - Majuru; Shingai ;   et al.
2010-03-18
Pharmaceutical Formulations Containing Microparticles Or Nanoparticles Of A Delivery Agent
App 20100055194 - Majuru; Shingai ;   et al.
2010-03-04
Disodium salts, monohydrates, and ethanol solvates for delivering active agents
Grant 7,659,311 - Bay , et al. February 9, 2
2010-02-09
Solid Pharmaceutical Dosage Forms Comprising Bisphosphonates And Modified Amino Acid Carriers
App 20090281064 - Ahmed; Hashim ;   et al.
2009-11-12
Oral Insulin Therapies & Protocol
App 20090253614 - ARBIT; Ehud ;   et al.
2009-10-08
Crystalline Polymorphic Forms Of Monosodium N-[-8-(2-Hydroxybenzoyl)Amino]Caprylate
App 20090143330 - Levchik; Halina ;   et al.
2009-06-04
Valacyclovir Formulations
App 20090124639 - Oyewumi; Moses ;   et al.
2009-05-14
Polymorphs Of Sodium 4-4[(4-chloro-2-hydroxybenzoyl) Amino] Butanoate
App 20090010882 - Bhandarkar; Satej ;   et al.
2009-01-08
Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino]butanoate
Grant 7,462,368 - Bhandarkar , et al. December 9, 2
2008-12-09
Disodium Salts, Monohydrates, And Ethanol Solvates For Delivering Active Agents
App 20080269134 - Bay; William E. ;   et al.
2008-10-30
Crystalline forms of the Di-Sodium Salt of N-(5-Chlorosalicyloyl)-8-Aminocaprylic Acid
App 20080269108 - Dhoot; Nikhil ;   et al.
2008-10-30
Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
Grant 7,420,085 - Bhandarkar , et al. September 2, 2
2008-09-02
Oral Insulin Therapies And Protocol
App 20080175907 - Arbit; Ehud ;   et al.
2008-07-24
Gastric Retention and Controlled Release Delivery System
App 20080153779 - Liao; Jun ;   et al.
2008-06-26
Disodium salts, monohydrates, and ethanol solvates for delivering active agents
Grant 7,384,982 - Bay , et al. June 10, 2
2008-06-10
Compositions For Delivering Acyclovir
App 20080132527 - Adams; Amy C. ;   et al.
2008-06-05
Compounds and compositions for delivering active agents
Grant 7,351,741 - Weidner , et al. April 1, 2
2008-04-01
Polymorphs Of Sodium 4-[(4-chloro-2-hydroxybenzoyl) Amino] Butanoate
App 20080033204 - Bhandarkar; Satej ;   et al.
2008-02-07
Solid Dosage Form of Wetted Heparin
App 20070224262 - Majuru; Shingai ;   et al.
2007-09-27
Polymorphs Of Sodium 4-[(4-chloro-2-hydroxybenzoyl) Amino] Butanoate
App 20070161708 - Bhandarkar; Satej ;   et al.
2007-07-12
Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
Grant 7,227,033 - Bhandarkar , et al. June 5, 2
2007-06-05
Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
Grant 7,208,178 - Bhandarkar , et al. April 24, 2
2007-04-24
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
App 20070049557 - Ahmed; Hashim ;   et al.
2007-03-01
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
App 20060078623 - Dhoot; Nikhil ;   et al.
2006-04-13
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
App 20060078622 - Majuru; Shingai ;   et al.
2006-04-13
Polymorphs of sodium 4-{4-chloro-2-hydroxybenzoyl) amino} butanoate
App 20050272639 - Bhandarkar, Satej ;   et al.
2005-12-08
Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
App 20050250852 - Bhandarkar, Satej ;   et al.
2005-11-10
Oral insulin therapies and protocol
App 20050203001 - Arbit, Ehud ;   et al.
2005-09-15
Disodium salts, monohydrates, and ethanol solvates for delivering active agents
App 20040106825 - Bay, William E. ;   et al.
2004-06-03
Compounds and compositions for delivering active agents
App 20040048777 - Weidner, John J ;   et al.
2004-03-11
Disodium salts, monohydrates, and ethanol solvates for delivering active agents
App 20020065255 - Bay, William E. ;   et al.
2002-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed